MAPT and Alzheimer disease: There is no direct evidence for that, but atypical presentations are more frequently observed in patients with early onset of dementia (before age 65), are less frequently associated with the apolipoprotein E4 genotype, often progress more rapidly than typical AD with leading memory deficits in old age, and there may also be molecular differences in amyloid and tau pathophysiology [17].